Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Keratin 17 (KRT17) Peptide

KRT17 Reactivité: Humain Hôte: Synthetic BP, WB, IHC
N° du produit ABIN979121
  • Antigène Tous les produits KRT17
    KRT17 (Keratin 17 (KRT17))
    Origine
    Humain
    Source
    • 3
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-KRT17 antibody (Catalog #: ARP41733_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Indications d'application
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    KRT17 (Keratin 17 (KRT17))
    Synonymes
    K17 Peptide, Krt1-17 Peptide, PC Peptide, PC2 Peptide, PCHC1 Peptide, Ka17 Peptide, KRT17 Peptide, krt16 Peptide, si:dkeyp-113d7.7 Peptide, KRT14 Peptide, keratin 17 Peptide, keratin 17 L homeolog Peptide, keratin 17, type I Peptide, keratin, type I cytoskeletal 17 Peptide, Krt17 Peptide, KRT17 Peptide, krt17 Peptide, krt17.L Peptide, LOC100737113 Peptide, LOC102177275 Peptide
    Sujet
    KRT17 is type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in its gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.KRT17 encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.

    Alias Symbols: K17, PC, PC2, PCHC1

    Protein Interaction Partner: CCDC85B,EGFR,KRT6A,KRT7,CCDC85B,GRB2,KRT6A,KRT72,KRT8,UCHL1,USP1

    Protein Size: 432
    Poids moléculaire
    48 kDa
    ID gène
    3872
    NCBI Accession
    NM_000422, NP_000413
    UniProt
    Q04695
Vous êtes ici:
Support technique